Article info
PDFOriginal research
Effectiveness, safety and cost analysis of dalbavancin in clinical practice
- Correspondence to Dr Maria Arrieta-Loitegui, Pharmacy, Hospital Universitario 12 de Octubre, Madrid 28041, Spain; maria.arrieta{at}salud.madrid.org
Citation
Effectiveness, safety and cost analysis of dalbavancin in clinical practice
Publication history
- Received April 16, 2020
- Revised July 6, 2020
- Accepted July 14, 2020
- First published October 5, 2020.
Online issue publication
January 09, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.